A dominant role for non-MHC gene effects in susceptibility to cyclosporin A (CsA)-induced autoimmunity

Clinical and Experimental Immunology

Volumn 113, Issue 3, 1998, Pages 333-338

  Damoiseaux, J G M C ^a   Beijleveld, L J J ^a   Van Breda Vriesman, P J C ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Cyclosporin A; Non MHC; Rat; T cells

Indexed keywords

CYCLOSPORIN A;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; FEMALE; GENETIC SUSCEPTIBILITY; GRAFT VERSUS HOST REACTION; HELPER CELL; IMMUNOGENETICS; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE SUBPOPULATION;

ADOPTIVE TRANSFER; ANIMALS; AUTOIMMUNITY; CD4-CD8 RATIO; CYCLOSPORINE; FEMALE; IMMUNOSUPPRESSIVE AGENTS; MAJOR HISTOCOMPATIBILITY COMPLEX; RATS; RATS, INBRED BN; RATS, INBRED LEW;

EID: 0031710234     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00667.x     Document Type: Article

References (39)

1. Happ MP, Wettstein P, Dietzschold B et al. Genetic control of the development of experimental allergic encephalomyelitis in rats. Separation of MHC and non-MHC gene effects. J Immunol 1988; 141:1489-94.
2. Vingsbo C, Johnsson R, Holmdahl R. Avridine-induced arthritis in rats: a T cell-dependent chronic disease influenced both by MHC genes and by non-MHC genes. Clin Exp Immunol 1995; 99:359-63.
3. Lorentzen JC, Klareskog L. Susceptibility of DA rats to arthritis induced with adjuvant oil or rat collagen is determined by genes both within and outside the major histocompatibility complex. Scand J Immunol 1996; 44:592-8.
4. Glazier A, Tutschka PJ, Farmer ER et al. Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution. J Exp Med 1983; 158:1-8.
5. Jones RS, Hess AD, Mann RB et al. Induction of graft-versus-host disease after autologous hone marrow transplantation. Lancet 1989; 1:754-47.
6. Bos GMJ, Majoor GD, Willighagen RGJ et al. Chronic cyclosporine-induced autoimmune disease in the rat: a new experimental model for scleroderma. J Invest Dermatol 1989; 93:610-5.
7. Damoiseaux JGMC, Beijleveld LJJ, van Breda Vriesman PJC. Cutaneous immunopathology of Cyclosporin-A induced autoimmunity in the rat. Clin Immunol Immunopathol 1995; 77:315-23.
8. Damoiseaux JGMC, Beijleveld LJJ, van Breda Vriesman PJC. Multiple effects of Cyclosporin-A on the thymus in relation to T-cell development and autoimmunity. Clin Immunol Immunopathol 1997; 82:197-202.
9. Damoiseaux JGMC, van Breda Vriesman PJC. Cyclosporin A-induced autoimmunity: the result of defective de novo T-cell development. Folia Biologica 1998; 44:1-9.
10. Sorokin R, Kimura H, Schroder K et al. Cyclosporin-induced autoimmunity: conditions for expressing disease, requirement for intact thymus, and potency estimates of autoimmune lymphocytes in drug-treated rats. J Exp Med 1986; 164:1615-25.
11. Beijleveld LJJ, Damoiseaux JGMC, Wodzig KWH et al. X-irradiation of the thymus is not required for the induction of Cyclosporin-A induced autoimmunity. Transplantation 1995; 59:1601-5.
12. Beijleveld LJJ, Damoiseaux JGMC, Roglic M et al. The lesions of cyclosporine-induced autoimmune disease can be equally well elicited by CD4 or CD8 effector T cells. Transplantation 1996; 62:1468-76.
13. Wodzig KWH, Majoor GD, van Breda Vriesman PJC. Susceptibility and resistance to Cyclosporin A-induced autoimmunity in rats. Autoimmunity 1993; 16:29-37.
14. +RT6 T helper cells. Clin Exp Immunol 1996; 105:486-96.
15. Annual Report. Central Institute for Laboratory Animal Breeding, World Health Organisation Collaborating Centre for Defined Laboratory Animals. Hannover: Central Institute for Laboratory Animal Breeding, 1988.
16. Wodzig KWH, Majoor GD, van Breda Vriesman PJC. On the localization of effector cells in cyclosporin-induced autoimmunity. Autoimmunity 1991; 10:275-83.
17. Hünig T, Wallny H-J, Hartley JK et al. A monoclonal antibody to a constant determinant of the rat T cell antigen receptor that induces T cell activation. J Exp Med 1989; 169:73-86.
18. Torres-Nagel NE, Gold DP, Hünig T. Identification of rat Terb-V8.2, 8.5, and 10 gene products by monoclonal antibodies. Immunogenet 1993; 37:305-8.
19. Torres-Nagel N, Kraus E, Brown MH et al. Differential thymus dependence of rat CD8 isoform expression. Eur J Immunol 1992; 22:2841-8.
20. Kumpinga J, Kroese FG, Pol GH et al. A monoclonal antibody to a determinant of the rat T cell antigen receptor expressed by a minor subset of T cells. Int Immunol 1989; 1:289-95.
21. Dijkstra CD, Döpp EA, Joling P et al. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology 1985; 54:589-99.
22. Damoiseaux JGMC, Döpp EA, Calame W et al. Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1. Immunology 1994; 83:140-7.
23. Williams AF, Galfre G, Milstein C. Analysis of cell surfaces by xenogeneic myeloma-hybrid antibodies: differentiation antigens of rat lymphocytes. Cell 1977; 12:663-73.
24. McMaster WR, Williams AF. Identitication of Ia glycoproteins in rat thymus and purification from rat spleen. Eur J Immunol 1979; 9:426-33.
25. Fangmann J, Schwinzer R, Winkler M et al. Expression of RT6 alloantigens and the T cell receptor on intestinal intraepithelial lymphocytes of the rat. Transplant Proc 1990; 22:2543-4.
26. Butcher GW. A list of monoclonal antibodies specific for alloantigens of the rat. J Immunogenetics 1987; 14:162-76.
27. Kampinga J, Groen H, Klatter FA et al. Post-thymic T-cell development in the rat. Thymus 1997; 24:173-200.
28. Yang C, Bell EB. Functional maturation of recent thymic emigrants in the periphery: development of alloreactivity correlates with the cyclic expression of CD45RC isoforms. Eur J Immunol 1992; 22:2261-9.
29. Thiele H-G, Haag F, Nolte E. Asymmetric expression of RT6.1 and RT6.2 alloantigens in (RT6a x RT6b) F1 rats is due to a pretranslational mechanism. Transplant Proc 1993; 25:2786-8.
30. Gao EK, Lo D, Cheney R et al. Abnormal differentiation of thymocytes in mice treated with Cyclosporin A. Nature 1988; 336:176-9.
31. Jenkins MK, Schwartz, RH, Pardoll DM. Effects of Cyclosporin A on T cell development and clonal deletion. Science 1988; 241:1655-8.
32. Bryson JS, Caywood BE, Kaplan AM. Relationship of cyclosporin A-mediated inhibition of clonal deletion and development of syngeneic graft-versus-host disease. J Immunol 1991; 147:391-7.
33. + T lymphocytes induces diabetes in resistant biobreeding/worcester (BB/ W) rats. J Exp Med 1987; 166:461-75.
34. + T cells induce wasting disease with multiple organ pathology: prevention by the OX-22 low subset. J Exp Med 1990; 172:1701-8.
35. + T cells and their roles in the induction and prevention of autoimmunity. Immunol Rev 1991; 123:37-64.
36. + T cell subset that inhibits this autoimmune potential. J Exp Med 1993; 177:627-36.
37. Kosuda LL, Greiner DL, Bigazzi PE. Mercury-induced renal autoimmunity in BN → LEW-IN chimeric rats. Cell Immunol 1994; 155:77-94.
38. Scott B, Liblau R, Degermann S et al. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity 1994; 1:73-82.
39. Müssener A, Lorentzen JC, Kleinau S et al. Altered Th1/Th2 balance associated with non-major histocompatibility complex genes in collagen-induced arthritis in resistant and non-resistant rat strains. Eur J Immunol 1997; 27:695-9.